期刊文献+

晚期非小细胞肺癌同步放化疗临床疗效及安全性研究分析 被引量:2

Analysis of Clinical Efficacy and Safety of Concurrent Radiotherapy and Chemotherapy for Advanced Non Small Cell Lung Cancer
下载PDF
导出
摘要 目的本文就长春瑞滨联合顺铂方案化疗并与放疗联合治疗非小细胞肺癌的临床疗效以安全性进行观察。方法选择我院自2012年2月~2015年3月期间收治晚期非小细胞肺癌患者60例,并将其按照入院时间平均分为对照组和实验组,每组患者各30例,实验组患者接受NP方案化疗联合三维适形放疗,对照组患者接受单纯放疗,对比两组患者治疗后的临床效果。结果实验组患者同步放化疗后的临床效果好于对照组(P〈0.05)。结论在晚期非小细胞肺癌治疗过程中选择长春瑞滨联合顺铂方案化疗联合并与放疗联合,不仅提高了治疗效果,同时延长了患者的生存时间。 Objective To observe the clinical efficacy of the treatment of non small cell lung cancer combined with cisplatin chemotherapy combined with radiotherapy and chemotherapy in Changchun. Methods In our hospital from February 2012 to 2015 during March were advanced non small cell lung cancer 60 patients and the according to the time of admission were divided into experimental group and control group. Patients in each group of 30 cases, the patients in the experimental group received NP chemotherapy combined with three dimensional conformal radiotherapy, patients in the control group received radiotherapy alone, compared with two groups of patients after clinical effect. Results The clinical effect of the experimental group was better than that of the control group(P〈0.05). Conclusion In advanced non small cell lung cancer treatment choice chemotherapy of vinorelbine combined with cisplatin in joint and combined with radiotherapy, not only improve the therapeutic effect, but also prolonged the survival time of the patients.
作者 陈静
机构地区 吉林省人民医院
出处 《中国卫生标准管理》 2015年第18期87-88,共2页 China Health Standard Management
关键词 晚期非小细胞肺癌 同步放化疗 临床疗效 安全性 Advanced non small cell lung cancer Concurrent radiotherapy and chemotherapy Clinical efficacy Safety
  • 相关文献

参考文献3

二级参考文献28

  • 1蒋月,葛红,单娟,沙永慧.化疗和放射治疗非小细胞肺癌的顺序与时机[J].肿瘤防治杂志,2005,12(19):1499-1501. 被引量:7
  • 2李广太,张士伟,宋学茹,钟述猷,刘政,尉建华,杨金富,米保香.妇科肿瘤患者外周血淋巴细胞亚群研究[J].中国肿瘤临床,1996,23(7):504-508. 被引量:17
  • 3Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada[J].J Natl Cancer Inst,2000,92(3):205-216.
  • 4Trotti A,Byhardt R,Stetz J,et al.Common toxicity criteria:version 2.0.an improved reference for grading the acute effects of cancer treatment:impact on radiotherapy[J].Int J Radiat Oncol Biol Phys,2000,47(1):13-47.
  • 5Patel S,Sanborn RE,Thomas CR Jr.Definitive chemoradiotherapy for non-small cell lung cancer with N2 disease[J].Thorac Surg Clin,2001,18(4):393-398.
  • 6Nozoe T,Saeki H,Ito S,et al.Preoperative hyperthermochemoradiotherapy for esophageal carcinoma[J].Surgery,2002,131(1 Suppl):S35-S38.
  • 7Brozovic A.Simaga S,Osmak M.Induction of heat shock protein 70 in drug-resistant cells by anticancer drugs and hyperthermia[J].Neoplasma,2001,48(2):99-103.
  • 8Nikfarjam M,Muralidharan V,Malcontenti-Wilson C,et al.The apoptotic response of liver and colorectal liver metastases to focal hyperthermic injury[J].Anticancer Res,2005,25(2B):1413-1419.
  • 9Sawaji Y,Sato T,Takeuchi A,et al.Anti-angiogenic action of hypethermia by suppressing gene expression and production of tumourderived vascular endothelial growth factor in vivo and in vitro[J].Br J Cancer,2002,86(10):1597-1603.
  • 10Zolzer F,Streffer C.G2-phase delays after irradiation and/or heat treatment as assessed by two-parameter flow cytometry[J].Radiat Res,2001,155(1 Pt 1):50-56.

共引文献46

同被引文献13

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部